title: Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine.
abstract: There are few reports in the literature and scarce research on the topic and the treatment of antipsychotic medication-induced urinary incontinence or nocturnal enuresis (NE) despite the significant frequency of these adverse effects.Treatment for antipsychotic medication-induced urinary incontinence has been reported in relation to clozapine with response to numerous pharmacological strategies such as ephedrine, oxybutynin, intranasal desmopressin, trihexyphenidyl, and amitriptyline.We report a case of NE induced by risperidone which has been successfully treated with reboxetine.To the best of our knowledge, this article is the first report of an atypical antipsychotic medication-induced NE treated with reboxetine.Reboxetine may be an effective treatment for risperidone-induced NE. Further research is required to confirm our finding and apply this treatment for NE caused by other neuroleptics.
authors.affiliation: Department of Consultation and Liaison Psychiatry, Shaare Zedek Medical Center, affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.
authors.forename: Joseph
authors.initials: J
authors.lastname: Mergui
authors.forename: Sol
authors.initials: S
authors.lastname: Jaworowski
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D009025:Morpholines / Q000627:therapeutic use*; D053206:Nocturnal Enuresis / Q000139:chemically induced* / Q000188:drug therapy*; D000077593:Reboxetine; D018967:Risperidone / Q000009:adverse effects*
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D009025:Morpholines; D000077593:Reboxetine; D018967:Risperidone